ASSERTIO HOLDINGS INC (ASRT)       6.105  +0.11 (+1.75%)

6.105  +0.11 (+1.75%)

US04546C2052 - Common Stock

ASSERTIO HOLDINGS INC6.105

NASDAQ:ASRT (3/28/2023, 8:48:05 AM)+0.11 (+1.75%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)03-08 2023-03-08/amc
Earnings (Next)05-08 2023-05-08/amc
Ins Owners2.75%
Inst Owners33.78%
Market Cap339.31M
Shares55.58M
PE3.43
Fwd PE11.09
Dividend YieldN/A
Analysts82.22
IPO02-12 1997-02-12

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ASRT Daily chart

Company Profile

Assertio Holdings, Inc. is a commercial pharmaceutical company offering differentiated products to patients utilizing a non-personal promotional model. The Company’s commercial portfolio of branded products focuses on three areas: neurology, rheumatology, and pain and inflammation. Its primary marketed products include INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Otrexup (methotrexate) injection for subcutaneous use, Sympazan (clobazam) oral film, SPRIX (ketorolac tromethamine) Nasal Spray, CAMBIA (diclofenac potassium for oral solution) and Zipso (diclofenac potassium) Liquid filled capsules. Its other commercially available products include OXAYDO (oxycodone HCI, USP) tablets for oral use. INDOCIN (indomethacin) Suppositories are nonsteroidal anti-inflammatory drug (NSAID), indicated for moderate to severe rheumatoid arthritis, including acute flares of chronic diseases, moderate to severe ankylosing spondylitis, acute gouty arthritis and others.

Company Info

ASSERTIO HOLDINGS INC

100 S. Saunders Road, Suite 300

Lake Forest ILLINOIS 60045

P: 12244197106.0

CEO: Daniel A. Peisert

Employees: 30

Website: https://www.assertiotx.com/

ASRT News

News Image20 days ago - Seeking AlphaAssertio Therapeutics Non-GAAP EPS of $0.32 beats by $0.12, revenue of $50.35M beats by $2.91M (NASDAQ:ASRT)

Assertio Therapeutics press release (ASRT): Q4 Non-GAAP EPS of $0.32 beats by $0.12.Revenue of $50.35M (+51.1% Y/Y) beats by $2.91M.Adjusted EBITDA increased to $33.4 million,...

News Image20 days ago - Assertio Holdings, Inc.Assertio Reports Fourth Quarter and Full Year 2022 Financial Results

Net Product Sales Increase 55% in the Fourth Quarter, 42% for the Full Year Full Year Net Income Increases to $109.6 Million, Non-GAAP Adjusted EBITDA...

News Image22 days ago - Assertio Holdings, Inc.Assertio Appoints Dr. Howard Franklin as Senior Vice President, Medical

LAKE FOREST, Ill., March 06, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical...

News Image22 days ago - InvestorPlace7 Thrilling Stocks to Buy for Aggressive Investors

Sometimes you need to be aggressive to unlock the best returns for your portfolio. Just be smart when looking for the best stocks to buy.

News Imagea month ago - Assertio Holdings, Inc.Assertio Announces Exchange Offer of $30 Million of its Currently Outstanding 6.50% Convertible Senior Notes Due 2027

LAKE FOREST, Ill., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio”) (NASDAQ: ASRT), a specialty pharmaceutical company offering...

News Imagea month ago - Seeking AlphaAssertio sees Q4 adjusted earnings of $0.31-$0.32 (NASDAQ:ASRT)

Assertio (ASRT) has reported prelim net product sales of $49M-$50M (vs. $46.90M estimated) for its fourth quarter, representing an year-over-year growth of at least 54%

ASRT Twits

Here you can normally see the latest stock twits on ASRT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example